Share-based Payment Arrangement, Noncash Expense of Medpace Holdings, Inc. from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncash expense for share-based payment arrangement.
Summary
Medpace Holdings, Inc. quarterly and annual Share-based Payment Arrangement, Noncash Expense in USD history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • Medpace Holdings, Inc. Share-based Payment Arrangement, Noncash Expense for the quarter ending 31 Dec 2025 was $5,620,000, a 4.6% decline year-over-year.
  • Medpace Holdings, Inc. Share-based Payment Arrangement, Noncash Expense for the twelve months ending 31 Dec 2025 was $34,786,000, a 36% increase year-over-year.
  • Medpace Holdings, Inc. annual Share-based Payment Arrangement, Noncash Expense for 2025 was $34,786,000, a 36% increase from 2024.
  • Medpace Holdings, Inc. annual Share-based Payment Arrangement, Noncash Expense for 2024 was $25,514,000, a 24% increase from 2023.
  • Medpace Holdings, Inc. annual Share-based Payment Arrangement, Noncash Expense for 2023 was $20,516,000, a 4.2% decline from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Noncash Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Noncash Expense, Quarterly (USD)
Share-based Payment Arrangement, Noncash Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Noncash Expense, Annual (USD)
Share-based Payment Arrangement, Noncash Expense, YoY Annual Change (%)

Medpace Holdings, Inc. Quarterly Share-based Payment Arrangement, Noncash Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $34,786,000 $5,620,000 -$269,000 -4.6% 01 Oct 2025 31 Dec 2025 10-K 10 Feb 2026 2025 FY
Q3 2025 $35,055,000 $6,323,000 -$5,404,000 -46% 01 Jul 2025 30 Sep 2025 10-Q 23 Oct 2025 2025 Q3
Q2 2025 $40,459,000 $5,951,000 +$2,363,000 +66% 01 Apr 2025 30 Jun 2025 10-Q 22 Jul 2025 2025 Q2
Q1 2025 $38,096,000 $16,892,000 +$12,582,000 +292% 01 Jan 2025 31 Mar 2025 10-Q 22 Apr 2025 2025 Q1
Q4 2024 $25,514,000 $5,889,000 +$724,000 +14% 01 Oct 2024 31 Dec 2024 10-K 10 Feb 2026 2025 FY
Q3 2024 $24,790,000 $11,727,000 +$6,720,000 +134% 01 Jul 2024 30 Sep 2024 10-Q 23 Oct 2025 2025 Q3
Q2 2024 $18,070,000 $3,588,000 -$1,318,000 -27% 01 Apr 2024 30 Jun 2024 10-Q 22 Jul 2025 2025 Q2
Q1 2024 $19,388,000 $4,310,000 -$1,128,000 -21% 01 Jan 2024 31 Mar 2024 10-Q 22 Apr 2025 2025 Q1
Q4 2023 $20,516,000 $5,165,000 -$428,000 -7.7% 01 Oct 2023 31 Dec 2023 10-K 10 Feb 2026 2025 FY
Q3 2023 $20,944,000 $5,007,000 -$787,000 -14% 01 Jul 2023 30 Sep 2023 10-Q 22 Oct 2024 2024 Q3
Q2 2023 $21,731,000 $4,906,000 -$747,000 -13% 01 Apr 2023 30 Jun 2023 10-Q 23 Jul 2024 2024 Q2
Q1 2023 $22,478,000 $5,438,000 +$1,066,000 +24% 01 Jan 2023 31 Mar 2023 10-Q 23 Apr 2024 2024 Q1
Q4 2022 $21,412,000 $5,593,000 +$1,612,000 +40% 01 Oct 2022 31 Dec 2022 10-K 11 Feb 2025 2024 FY
Q3 2022 $19,800,000 $5,794,000 +$1,747,000 +43% 01 Jul 2022 30 Sep 2022 10-Q 24 Oct 2023 2023 Q3
Q2 2022 $18,053,000 $5,653,000 +$2,083,000 +58% 01 Apr 2022 30 Jun 2022 10-Q 25 Jul 2023 2023 Q2
Q1 2022 $15,970,000 $4,372,000 +$1,501,000 +52% 01 Jan 2022 31 Mar 2022 10-Q 25 Apr 2023 2023 Q1
Q4 2021 $14,469,000 $3,981,000 +$1,020,000 +34% 01 Oct 2021 31 Dec 2021 10-K 13 Feb 2024 2023 FY
Q3 2021 $13,449,000 $4,047,000 +$1,285,000 +47% 01 Jul 2021 30 Sep 2021 10-Q 25 Oct 2022 2022 Q3
Q2 2021 $12,164,000 $3,570,000 +$954,000 +36% 01 Apr 2021 30 Jun 2021 10-Q 26 Jul 2022 2022 Q2
Q1 2021 $11,210,000 $2,871,000 -$2,574,000 -47% 01 Jan 2021 31 Mar 2021 10-Q 26 Apr 2022 2022 Q1
Q4 2020 $13,784,000 $2,961,000 +$254,000 +9.4% 01 Oct 2020 31 Dec 2020 10-K 14 Feb 2023 2022 FY
Q3 2020 $13,530,000 $2,762,000 -$6,704,000 -71% 01 Jul 2020 30 Sep 2020 10-Q 26 Oct 2021 2021 Q3
Q2 2020 $20,234,000 $2,616,000 -$2,769,000 -51% 01 Apr 2020 30 Jun 2020 10-Q 27 Jul 2021 2021 Q2
Q1 2020 $23,003,000 $5,445,000 +$2,262,000 +71% 01 Jan 2020 31 Mar 2020 10-Q 27 Apr 2021 2021 Q1
Q4 2019 $20,741,000 $2,707,000 +$594,000 +28% 01 Oct 2019 31 Dec 2019 10-K 15 Feb 2022 2021 FY
Q3 2019 $20,147,000 $9,466,000 +$8,034,000 +561% 01 Jul 2019 30 Sep 2019 10-Q 27 Oct 2020 2020 Q3
Q2 2019 $12,113,000 $5,385,000 +$3,898,000 +262% 01 Apr 2019 30 Jun 2019 10-Q 28 Jul 2020 2020 Q2
Q1 2019 $8,215,000 $3,183,000 +$1,716,000 +117% 01 Jan 2019 31 Mar 2019 10-Q 29 Apr 2020 2020 Q1
Q4 2018 $6,499,000 $2,113,000 +$865,000 +69% 01 Oct 2018 31 Dec 2018 10-K 16 Feb 2021 2020 FY
Q3 2018 $5,634,000 $1,432,000 +$451,000 +46% 01 Jul 2018 30 Sep 2018 10-Q 29 Oct 2019 2019 Q3
Q2 2018 $5,183,000 $1,487,000 +$287,000 +24% 01 Apr 2018 30 Jun 2018 10-Q 30 Jul 2019 2019 Q2
Q1 2018 $4,896,000 $1,467,000 +$433,000 +42% 01 Jan 2018 31 Mar 2018 10-Q 30 Apr 2019 2019 Q1
Q4 2017 $4,463,000 $1,248,000 01 Oct 2017 31 Dec 2017 10-K 25 Feb 2020 2019 FY
Q3 2017 $981,000 01 Jul 2017 30 Sep 2017 10-Q 30 Oct 2018 2018 Q3
Q2 2017 $1,200,000 01 Apr 2017 30 Jun 2017 10-Q 31 Jul 2018 2018 Q2
Q1 2017 $1,034,000 +$25,000 +2.5% 01 Jan 2017 31 Mar 2017 10-Q 01 May 2018 2018 Q1
Q1 2016 $1,009,000 01 Jan 2016 31 Mar 2016 10-Q 02 May 2017 2017 Q1

Medpace Holdings, Inc. Annual Share-based Payment Arrangement, Noncash Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $34,786,000 +$9,272,000 +36% 01 Jan 2025 31 Dec 2025 10-K 10 Feb 2026 2025 FY
2024 $25,514,000 +$4,998,000 +24% 01 Jan 2024 31 Dec 2024 10-K 10 Feb 2026 2025 FY
2023 $20,516,000 -$896,000 -4.2% 01 Jan 2023 31 Dec 2023 10-K 10 Feb 2026 2025 FY
2022 $21,412,000 +$6,943,000 +48% 01 Jan 2022 31 Dec 2022 10-K 11 Feb 2025 2024 FY
2021 $14,469,000 +$685,000 +5% 01 Jan 2021 31 Dec 2021 10-K 13 Feb 2024 2023 FY
2020 $13,784,000 -$6,957,000 -34% 01 Jan 2020 31 Dec 2020 10-K 14 Feb 2023 2022 FY
2019 $20,741,000 +$14,242,000 +219% 01 Jan 2019 31 Dec 2019 10-K 15 Feb 2022 2021 FY
2018 $6,499,000 +$2,036,000 +46% 01 Jan 2018 31 Dec 2018 10-K 16 Feb 2021 2020 FY
2017 $4,463,000 -$5,352,000 -55% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020 2019 FY
2016 $9,815,000 -$12,509,000 -56% 01 Jan 2016 31 Dec 2016 10-K 26 Feb 2019 2018 FY
2015 $22,324,000 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.